Literature DB >> 22614780

Predictors of survival in children born with Down syndrome: a registry-based study.

Judith Rankin1, Peter W G Tennant, Mary Bythell, Mark S Pearce.   

Abstract

OBJECTIVE: To examine the influence of fetal and maternal characteristics on the survival of children born with Down syndrome.
METHODS: We used prospectively collected population-based data on Down syndrome extracted from the UK Northern Congenital Abnormality Survey (NorCAS), January 1, 1985-December 31, 2003, matched to hospital and national mortality records to January 29, 2008, to determine survival status of liveborn children. Survival to 20 years was estimated by using Kaplan-Meier methods. Cox proportional hazards regression was used to examine factors that predict survival.
RESULTS: A total of 1115 Down syndrome pregnancies were notified to NorCAS during the 19 years, a total prevalence of 16.8 (95% CI, 15.8-17.8) per 10,000 live births and stillbirths. Of these, 5.4% resulted in a spontaneous fetal loss (late miscarriage ≥ 20 weeks and stillbirth), 31.7% in a termination of pregnancy, and 63.0% in a live birth. Survival status was known for 95.3% of live births; 16.6% resulted in a death. Year of birth (P < .001), gestational age at delivery (P < .001), standardized birth weight (P < .001), karyotype (P < .01), and presence of additional structural anomalies (P < .001) were significant predictors of survival. Infant gender, plurality, maternal age, and maternal deprivation were not significant predictors of survival.
CONCLUSIONS: These robust estimates of predictors of survival are important for the prenatal counseling of parents whose pregnancy is affected by Down syndrome and for health care planning for the future care needs of these children.

Entities:  

Mesh:

Year:  2012        PMID: 22614780     DOI: 10.1542/peds.2011-3051

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Transient abnormal myelopoiesis/acute megakaryoblastic leukemia diagnosed in the placenta of a stillborn Down syndrome fetus with targeted next-generation sequencing.

Authors:  B Federmann; A Fasan; K O Kagan; S Haen; F Fend
Journal:  Leukemia       Date:  2014-09-02       Impact factor: 11.528

2.  Morbidity and mortality in neonates with Down Syndrome based on gestational age.

Authors:  Emily A Messick; Carl H Backes; Kenneth Jackson; Sara Conroy; Stephen A Hart; Clifford L Cua
Journal:  J Perinatol       Date:  2022-09-21       Impact factor: 3.225

3.  Prevalence of structural birth defects among infants with Down syndrome, 2013-2017: A US population-based study.

Authors:  Dominique Heinke; Jennifer L Isenburg; Erin B Stallings; Tyiesha D Short; Mimi Le; Sarah Fisher; Xiaoyi Shan; Russell S Kirby; Hoang H Nguyen; Eirini Nestoridi; Wendy N Nembhard; Paul A Romitti; Jason L Salemi; Philip J Lupo
Journal:  Birth Defects Res       Date:  2020-12-21       Impact factor: 2.661

4.  Pain in Intellectually Disabled Children: Towards Evidence-Based Pharmacotherapy?

Authors:  Abraham J Valkenburg; Tom G de Leeuw; Monique van Dijk; Dick Tibboel
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

5.  Negotiating acceptable termination of pregnancy for non-lethal fetal anomaly: a qualitative study of professional perspectives.

Authors:  Lisa Crowe; Ruth H Graham; Stephen C Robson; Judith Rankin
Journal:  BMJ Open       Date:  2018-03-01       Impact factor: 2.692

6.  Congenital Cardiovascular Anomalies among Cases of Down Syndrome: A Hospital Based Review of Cases in TikurAnbessa Specialized Hospital, Ethiopia.

Authors:  Ahmed Muntha; Tamirat Moges
Journal:  Ethiop J Health Sci       Date:  2019-03

7.  Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study.

Authors:  Anda-Cornelia Vizitiu; Danae Stambouli; Anca-Gabriela Pavel; Maria-Cezara Muresan; Diana Maria Anastasiu; Cristina Bejinar; Anda Alexa; Catalin Marian; Ioan Ovidiu Sirbu; Laurentiu Sima
Journal:  Medicina (Kaunas)       Date:  2019-11-07       Impact factor: 2.430

8.  Causes of death in patients with Down syndrome in 2014-2016: A population study in Japan.

Authors:  Narumi Motegi; Yui Yamaoka; Akinori Moriichi; Naho Morisaki
Journal:  Am J Med Genet A       Date:  2021-10-07       Impact factor: 2.578

9.  GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.

Authors:  Irene Roberts; Kate Alford; Georgina Hall; Gaetan Juban; Helen Richmond; Alice Norton; Grant Vallance; Kelly Perkins; Emanuele Marchi; Simon McGowan; Anindita Roy; Gillian Cowan; Mark Anthony; Amit Gupta; John Ho; Sabita Uthaya; Anna Curley; Shree Vishna Rasiah; Timothy Watts; Richard Nicholl; Alison Bedford-Russell; Raoul Blumberg; Angela Thomas; Brenda Gibson; Chris Halsey; Pek-Wan Lee; Sunit Godambe; Connor Sweeney; Neha Bhatnagar; Anne Goriely; Peter Campbell; Paresh Vyas
Journal:  Blood       Date:  2013-09-10       Impact factor: 25.476

Review 10.  Neuro-Ophthalmological Manifestations in Children with Down Syndrome: Current Perspectives.

Authors:  Lavinia Postolache; Anne Monier; Sophie Lhoir
Journal:  Eye Brain       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.